Follow
Efstathios Iliodromitis
Efstathios Iliodromitis
Verified email at med.uoa.gr
Title
Cited by
Cited by
Year
2015 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation
M Roffi, C Patrono, JP Collet, C Mueller, M Valgimigli, F Andreotti, JJ Bax, ...
Polish Heart Journal (Kardiologia Polska) 73 (12), 1207-1294, 2015
12353*2015
Effect of colchicine vs standard care on cardiac and inflammatory biomarkers and clinical outcomes in patients hospitalized with coronavirus disease 2019: the GRECCO-19 …
SG Deftereos, G Giannopoulos, DA Vrachatis, GD Siasos, SG Giotaki, ...
JAMA network open 3 (6), e2013136-e2013136, 2020
4602020
The olive constituent oleuropein exhibits anti-ischemic, antioxidative, and hypolipidemic effects in anesthetized rabbits
I Andreadou, EK Iliodromitis, E Mikros, M Constantinou, A Agalias, ...
The journal of nutrition 136 (8), 2213-2219, 2006
3862006
Practical guidelines for rigor and reproducibility in preclinical and clinical studies on cardioprotection
HE Bøtker, D Hausenloy, I Andreadou, S Antonucci, K Boengler, ...
Basic research in cardiology 113, 1-73, 2018
3692018
Ischaemic conditioning and targeting reperfusion injury: a 30 year voyage of discovery
DJ Hausenloy, JA Barrabes, HE Bøtker, SM Davidson, F Di Lisa, ...
Basic research in cardiology 111, 1-24, 2016
3392016
Acute doxorubicin cardiotoxicity is successfully treated with the phytochemical oleuropein through suppression of oxidative and nitrosative stress
I Andreadou, F Sigala, EK Iliodromitis, M Papaefthimiou, C Sigalas, ...
Journal of molecular and cellular cardiology 42 (3), 549-558, 2007
2872007
Ischemic postconditioning: experimental models and protocol algorithms
A Skyschally, P Van Caster, EK Iliodromitis, R Schulz, DT Kremastinos, ...
Basic research in cardiology 104, 469-483, 2009
2542009
Effects of levosimendan on circulating pro-inflammatory cytokines and soluble apoptosis mediators in patients with decompensated advanced heart failure
JT Parissis, S Adamopoulos, C Antoniades, G Kostakis, A Rigas, ...
The American journal of cardiology 93 (10), 1309-1312, 2004
2422004
The role of gasotransmitters NO, H2S and CO in myocardial ischaemia/reperfusion injury and cardioprotection by preconditioning, postconditioning and remote …
I Andreadou, EK Iliodromitis, T Rassaf, R Schulz, A Papapetropoulos, ...
British journal of pharmacology 172 (6), 1587-1606, 2015
2092015
Protection from postconditioning depends on the number of short ischemic insults in anesthetized pigs
EK Iliodromitis, M Georgiadis, MV Cohen, JM Downey, E Bofilis, ...
Basic research in cardiology 101, 502-507, 2006
1762006
The effectiveness of postconditioning and preconditioning on infarct size in hypercholesterolemic and normal anesthetized rabbits
EK Iliodromitis, A Zoga, A Vrettou, I Andreadou, IA Paraskevaidis, ...
Atherosclerosis 188 (2), 356-362, 2006
1692006
The Greek study in the effects of colchicine in COvid-19 complications prevention (GRECCO-19 study): Rationale and study design
SG Deftereos, G Siasos, G Giannopoulos, DA Vrachatis, C Angelidis, ...
Hellenic journal of cardiology 61 (1), 42-45, 2020
1682020
Effects of levosimendan versus dobutamine on inflammatory and apoptotic pathways in acutely decompensated chronic heart failure
S Adamopoulos, JT Parissis, EK Iliodromitis, I Paraskevaidis, D Tsiapras, ...
The American journal of cardiology 98 (1), 102-106, 2006
1632006
Increased C reactive protein and cardiac enzyme levels after coronary stent implantation. Is there protection by remote ischaemic preconditioning?
EK Iliodromitis, S Kyrzopoulos, IA Paraskevaidis, KG Kolocassides, ...
Heart 92 (12), 1821-1826, 2006
1542006
Catheter ablation for atrial fibrillation in patients with left ventricular systolic dysfunction. A systematic review and meta-analysis
N Dagres, C Varounis, T Gaspar, C Piorkowski, C Eitel, EK Iliodromitis, ...
Journal of cardiac failure 17 (11), 964-970, 2011
1332011
Effects of serial levosimendan infusions on left ventricular performance and plasma biomarkers of myocardial injury and neurohormonal and immune activation in patients with …
JT Parissis, S Adamopoulos, D Farmakis, G Filippatos, I Paraskevaidis, ...
Heart 92 (12), 1768-1772, 2006
1312006
Arrhythmic risk stratification in post-myocardial infarction patients with preserved ejection fraction: the PRESERVE EF study
KA Gatzoulis, D Tsiachris, P Arsenos, CK Antoniou, P Dilaveris, S Sideris, ...
European heart journal 40 (35), 2940-2949, 2019
1292019
Deferoxamine infusion during coronary artery bypass grafting ameliorates lipid peroxidation and protects the myocardium against reperfusion injury: immediate and long-term …
IA Paraskevaidis, EK Iliodromitis, D Vlahakos, DP Tsiapras, A Nikolaidis, ...
European heart journal 26 (3), 263-270, 2005
1282005
Ischemic preconditioning: protection against myocardial necrosis and apoptosis
EK Iliodromitis, A Lazou, DT Kremastinos
Vascular health and risk management 3 (5), 629-637, 2007
1262007
Effects of 6-month treatment with the glucagon like peptide-1 analogue liraglutide on arterial stiffness, left ventricular myocardial deformation and oxidative stress in …
V Lambadiari, G Pavlidis, F Kousathana, M Varoudi, D Vlastos, E Maratou, ...
Cardiovascular Diabetology 17, 1-12, 2018
1242018
The system can't perform the operation now. Try again later.
Articles 1–20